Sign in
4

Changes in Ownership

Transcode Therapeutics, Inc. Filed Acc 0001104659-26-091078

10% owner acquired 13,834,441 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DEFJ, LLC 10% owner 2026-08-03 Conversion +11,813,859 12,113,899 D: show line 1 in the form
DEFJ, LLC 10% owner 2026-08-03 Conversion +2,020,582 14,134,481 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
DEFJ, LLC 10% owner 2026-08-03 Conversion · Series A Non-Voting Convertible Preferred Stock −1,181.39 0 D: show line 3 in the form
DEFJ, LLC 10% owner 2026-08-03 Conversion · Series B Non-Voting Convertible Preferred Stock −202.06 0 D: show line 4 in the form
Loading xslF345X06/tm2622262-2_4seq1.xml…